Karol Białkowski

892 total citations
24 papers, 620 citations indexed

About

Karol Białkowski is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Karol Białkowski has authored 24 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Karol Białkowski's work include DNA Repair Mechanisms (10 papers), DNA and Nucleic Acid Chemistry (6 papers) and Glutathione Transferases and Polymorphisms (5 papers). Karol Białkowski is often cited by papers focused on DNA Repair Mechanisms (10 papers), DNA and Nucleic Acid Chemistry (6 papers) and Glutathione Transferases and Polymorphisms (5 papers). Karol Białkowski collaborates with scholars based in Poland, United States and Denmark. Karol Białkowski's co-authors include Kazimierz S. Kasprzak, Ryszard Oliński, Jan Lukszo, Wojciech Bal, Peter Möller, Steffen Loft, Marek Foksiński, Peter C. Dedon, J. Richard Wagner and Mark D. Evans and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Free Radical Biology and Medicine.

In The Last Decade

Karol Białkowski

23 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karol Białkowski Poland 14 425 145 78 71 67 24 620
Jolanta Guz Poland 15 462 1.1× 133 0.9× 67 0.9× 64 0.9× 142 2.1× 28 807
Anna Szpila Poland 14 459 1.1× 125 0.9× 61 0.8× 56 0.8× 124 1.9× 23 762
Shinji Oikawa Japan 8 210 0.5× 66 0.5× 62 0.8× 59 0.8× 63 0.9× 13 452
Sema Sentürker United States 12 646 1.5× 137 0.9× 20 0.3× 89 1.3× 65 1.0× 14 825
Terry D. Oberley United States 7 685 1.6× 178 1.2× 75 1.0× 80 1.1× 88 1.3× 8 890
Hiroshi Kasai Japan 9 412 1.0× 229 1.6× 68 0.9× 53 0.7× 80 1.2× 10 920
Sylvain Caillat France 12 312 0.7× 93 0.6× 78 1.0× 37 0.5× 39 0.6× 21 556
Leena Chaudhuri United States 10 393 0.9× 94 0.6× 32 0.4× 77 1.1× 41 0.6× 23 651
Iwona Buraczewska Poland 12 263 0.6× 198 1.4× 64 0.8× 59 0.8× 14 0.2× 31 551
Lixiang Yang China 16 322 0.8× 89 0.6× 22 0.3× 45 0.6× 38 0.6× 34 633

Countries citing papers authored by Karol Białkowski

Since Specialization
Citations

This map shows the geographic impact of Karol Białkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karol Białkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karol Białkowski more than expected).

Fields of papers citing papers by Karol Białkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karol Białkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karol Białkowski. The network helps show where Karol Białkowski may publish in the future.

Co-authorship network of co-authors of Karol Białkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Karol Białkowski. A scholar is included among the top collaborators of Karol Białkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karol Białkowski. Karol Białkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Misiak, Rana, et al.. (2025). Clinical Significance of NUDT1 (MTH1) Across Cancer Types. International Journal of Molecular Sciences. 26(11). 5137–5137.
2.
Białkowski, Karol & Anna Szpila. (2021). Specific 8-oxo-dGTPase activity of MTH1 (NUDT1) protein as a quantitative marker and prognostic factor in human colorectal cancer. Free Radical Biology and Medicine. 176. 257–264. 9 indexed citations
3.
Białkowski, Karol & Kazimierz S. Kasprzak. (2019). A profile of 8-oxo-dGTPase activities in the NCI-60 human cancer panel: Meta-analytic insight into the regulation and role of MTH1 (NUDT1) gene expression in carcinogenesis. Free Radical Biology and Medicine. 148. 1–21. 7 indexed citations
5.
Cadet, Jean, Steffen Loft, Ryszard Oliński, et al.. (2012). Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radical Research. 46(4). 367–381. 114 indexed citations
6.
Mikkelsen, Lone, Karol Białkowski, Lotte Risom, et al.. (2009). Aging and defense against generation of 8-oxo-7,8-dihydro-2′-deoxyguanosine in DNA. Free Radical Biology and Medicine. 47(5). 608–615. 41 indexed citations
7.
Białkowski, Karol, Anna Szpila, & Kazimierz S. Kasprzak. (2009). Up-regulation of 8-oxo-dGTPase Activity of MTH1 Protein in the Brain, Testes and Kidneys of Mice Exposed to137Cs γ Radiation. Radiation Research. 172(2). 187–197. 14 indexed citations
8.
Białkowski, Karol & Kazimierz S. Kasprzak. (2004). Cellular 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-triphosphate pyrophosphohydrolase activity of human and mouse MTH1 proteins does not depend on the proliferation rate. Free Radical Biology and Medicine. 37(10). 1534–1541. 7 indexed citations
9.
Białkowski, Karol & Kazimierz S. Kasprzak. (2003). Inhibition of 8-oxo-2′-deoxyguanosine 5′-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) activity of the antimutagenic human MTH1 protein by nucleoside 5′-diphosphates. Free Radical Biology and Medicine. 35(6). 595–602. 13 indexed citations
11.
Kasprzak, Kazimierz S. & Karol Białkowski. (2000). Inhibition of antimutagenic enzymes, 8-oxo-dGTPases, by carcinogenic metals. Recent developments. Journal of Inorganic Biochemistry. 79(1-4). 231–236. 43 indexed citations
13.
Białkowski, Karol, Aneta Białkowska, Lucy M. Anderson, & Kazimierz S. Kasprzak. (1999). Higher activity of 8-oxo-2′-deoxyguanosine 5′-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) coincides with lower background levels of 8-oxo-2′-deoxyguanosine in DNA of fetal compared with maternal mouse organs. Free Radical Biology and Medicine. 27(1-2). 90–94. 18 indexed citations
14.
Foksiński, Marek, et al.. (1999). Evaluation of 8-oxodeoxyguanosine, typical oxidative DNA damage, in lymphocytes of ozone-treated arteriosclerotic patients. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 438(1). 23–27. 37 indexed citations
15.
Białkowski, Karol & Ryszard Oliński. (1999). Oxidative damage to plant DNA in relation to growth conditions.. Acta Biochimica Polonica. 46(1). 43–49. 8 indexed citations
17.
Bal, Wojciech, Jan Lukszo, Karol Białkowski, & Kazimierz S. Kasprzak. (1998). Interactions of Nickel(II) with Histones:  Interactions of Nickel(II) with CH3CO-Thr-Glu-Ser-His-His-Lys-NH2, a Peptide Modeling the Potential Metal Binding Site in the “C-Tail” Region of Histone H2A. Chemical Research in Toxicology. 11(9). 1014–1023. 81 indexed citations
18.
Białkowski, Karol, et al.. (1997). Improved high-performance liquid chromatographic method for N-acetylgalactosamine-4-sulfate sulfatase (arylsulfatase B) activity determination using uridine diphosho-N-acetylgalactosamine-4-sulfate. Journal of Chromatography B Biomedical Sciences and Applications. 696(2). 193–202. 1 indexed citations
19.
Oliński, Ryszard, Paweł Jaruga, Marek Foksiński, Karol Białkowski, & Jerzy Tujakowski. (1997). Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy. Molecular Pharmacology. 52(5). 882–885. 34 indexed citations
20.
Białkowski, Karol, et al.. (1996). 8-Oxo-2′-deoxyguanosine level in lymphocytes DNA of cancer patients undergoing radiotherapy. Cancer Letters. 99(1). 93–97. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026